(Q34726910)

English

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies (English)

1 reference

Europe PubMed Central

4 August 2017

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hepatitis A vaccine

1 reference

based on heuristic

inferred from title

object named as

Murray Krahn

9

0 references

3

object named as

Chris T Bauch

1 reference

Europe PubMed Central

4 August 2017

Andrea C. Tricco

2

object named as

Andrea C Tricco

1 reference

Europe PubMed Central

4 August 2017

author name string

Andrea M Anonychuk

1

1 reference

Europe PubMed Central

4 August 2017

Ba' Pham

4

1 reference

Europe PubMed Central

4 August 2017

Vladimir Gilca

5

1 reference

Europe PubMed Central

4 August 2017

Bernard Duval

6

1 reference

Europe PubMed Central

4 August 2017

Ava John-Baptiste

7

1 reference

Europe PubMed Central

4 August 2017

Gloria Woo

8

1 reference

Europe PubMed Central

4 August 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

4 August 2017

PharmacoEconomics

1 reference

Europe PubMed Central

4 August 2017

26

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

17-32

1 reference

Europe PubMed Central

4 August 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200826010-00003

0 references

The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200826010-00003

21 January 2018

Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Universal mass vaccination against hepatitis A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of hepatitis A vaccination in healthcare workers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Institute for Clinical Excellence and its value judgments

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of hepatitis A and B vaccination programme in Germany

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-Effectiveness of Routine Childhood Vaccination for Hepatitis A in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic analysis of different strategies of immunization against hepatitis A virus in developed countries

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-utility analysis of hepatitis A prevention among health-care workers in Israel

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of a food-borne outbreak of hepatitis A in Denver, Colo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The quality of reporting in published cost-utility analyses, 1976-1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of vaccinating food service workers against hepatitis A infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing picture of hepatitis A in the United States.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The existence of publication bias and risk factors for its occurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effective analysis of hepatitis A prevention in Ireland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cost Effectiveness of Hepatitis Immunization for US College Students

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of hepatitis a vaccination in Italy: an economic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A vaccine: is it being used to best advantage?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A in the era of vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of hepatitis A prevention in France

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A virus infections in travelers, 1988-2004.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-utility of universal hepatitis A vaccination in Canada.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of hepatitis A infections in American adolescents and adults in 1997.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of vaccination against hepatitis A in travellers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Publication and related biases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rubella Immunity and Morbidity: Effects of Vaccination in Finland

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation under managed competition: evidence from the U.K.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of interventions triggered by hepatitis A infected food-handlers in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of hepatitis A prevention in travellers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interpretation of cost-effectiveness analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should British soldiers be vaccinated against hepatitis A? An economic analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-Effectiveness of Hepatitis A/B Vaccine versus Hepatitis B Vaccine in Public Sexually Transmitted Disease Clinics

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A--the price of progress

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bias in published cost effectiveness studies: systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of hepatitis A virus immunisation in Spain

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional variation in the cost effectiveness of childhood hepatitis A immunization

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An economic evaluation of hepatitis A vaccination in Dutch military personnel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of hepatitis A in Israel following universal immunization of toddlers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis of hepatitis A vaccination strategies for adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18088156

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200826010-00003

1 reference

Europe PubMed Central

4 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34726910&oldid=1569901469"